So, here's a thing that happens in tech: when a wave gets big enough, even the biggest ships in the harbor start talking about building a better boat together. That's essentially what International Business Machines Corp. (IBM) and Arm Holdings Plc (ARM) announced they're doing on Thursday. They're forming a strategic partnership to cook up a new kind of hardware built from the ground up for the era of artificial intelligence.
The plan is to create what they're calling "dual-architecture" systems. In plain English, that means hardware designed to run workloads efficiently across different computing architectures. The goal is to combine what each company does best: IBM's deep history in building reliable, secure, and massively scalable enterprise systems, with Arm's famously power-efficient chip designs and its vast ecosystem of software. The idea is to give businesses more flexible and scalable computing platforms, which is exactly what you need when you're trying to train a large language model or crunch petabytes of data.
Specifically, the companies say they'll focus on a few key areas. First, expanding virtualization to let Arm-based applications run smoothly on IBM's systems. Second, tweaking performance specifically for AI workloads. And third, building out a shared software ecosystem to make everything more compatible and easier to deploy. It's a recognition that as AI adoption accelerates, enterprise demand isn't just for raw power—it's for infrastructure that balances that power with portability, efficiency, and, crucially, security.
What's Going On With IBM's Stock?
While the partnership news is forward-looking, IBM's stock has been facing some headwinds in the near term. As of the latest data, the stock was trading around $242.60. That puts it about 1.8% below its 20-day simple moving average, which hints at some short-term weakness. The picture looks a bit more concerning over a slightly longer horizon, as it's also trading about 7.7% below its 50-day moving average. This suggests the stock has been struggling to maintain any upward momentum it had.
The Relative Strength Index (RSI), a common momentum gauge, is sitting at a neutral 44.80. That means the stock isn't in overbought or oversold territory, leaving the door open for a move in either direction depending on what catalysts come along. For traders watching the charts, key levels to note are resistance around $260.50—where any rally might stall—and support down near $220.50, which could attract buyers if the stock dips that low.
The Financial and Analyst Picture
Looking ahead, IBM is expected to report its next earnings on April 22, 2026. The estimates are pointing upward: analysts are forecasting earnings per share of $1.80, up from $1.60, and revenue of $15.60 billion, up from $14.54 billion. At a price-to-earnings ratio of about 21.8x, the market is essentially saying the stock is fairly valued—not a screaming bargain, but not excessively expensive either.
The overall analyst consensus remains a Buy rating, with an average price target of $282.06. However, the recent actions have been a mixed bag. In March, BMO Capital lowered its price target to $290 while maintaining a Market Perform rating, and JP Morgan lowered its target to $283 while keeping a Neutral stance. On the more bullish side, Wedbush maintained an Outperform rating with a $340 price target back in February.
When you break down IBM's profile against the broader market, you get a story of contrasts. Its quality score is strong at 79.2, reflecting a healthy balance sheet—a classic IBM strength. But its value score is weak at 24.57, meaning it trades at a premium compared to peers. Growth is neutral, and perhaps most telling for recent price action, its momentum score is very weak at 16.1, indicating the stock is underperforming the market. The verdict? A solid company foundationally, but one that the market isn't excited about right now.
ETF Exposure: The Automatic Buyer (or Seller)
Here's a quirk of modern markets that matters for a stock like IBM: its place in exchange-traded funds. IBM is a major holding in several dividend-focused technology ETFs. It makes up 4.59% of the Amplify CWP Enhanced Dividend Income ETF (DIVO), 7.48% of the First Trust NASDAQ Technology Dividend Index Fund (TDIV), and 6.84% of the FT Vest Technology Dividend Target Income ETF (TDVI).
Why does this matter? Because of how ETFs work. If investors pour money into these funds, the ETF managers have to go out and buy more IBM shares to maintain that target weight. Conversely, big outflows force selling. It creates a layer of automatic, non-discretionary trading around the stock that's based on fund flows, not necessarily IBM's specific news.
Speaking of price action, IBM shares were down 0.68% at $241.49 in premarket trading on Thursday, according to market data.
